COMMENT: Almost overnight, the affable ‘Game of Thrones’ star seems to have become the most in-demand actor in Hollywood.

Meet the author: Dr. Phil Plait is an astronomer, author, and science communicator with a PhD in astronomy at the University ...

A life sciences company is setting up shop in Durham to take advantage of the area's robust talent pool and thriving biotech ...

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

DA Davidson lowered the firm’s price target on Vertex (VERX) to $50 from $55 and keeps a Buy rating on the shares as part of a broader research ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $475.49, marking a -1.41% move from the previous day. The stock outperformed the S&P 500, which registered a daily loss of 3.46%.

Alexander Volkanovski is UFC featherweight champion once again. Volkanovski defeated Diego Lopes by unanimous decision in the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

© 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...